Oral Topotecan to Treat Recurrent or Persistent Solid Tumors
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the effectiveness of oral topotecan and how well the
chemotherapy is tolerated (any side effects) when it is given in different dose levels. The
study will also collect information on how the medication is being broken down and absorbed
in the body and how quality of life is affected during treatment.